Award
BPA Call #36C24526N0839
TAKHZYRO Drug Supply via BPA Call Contract to Takeda Pharmaceuticals
Buyer
Department of Veterans Affairs
Award Amount
$38,360.10
Ceiling
$38,360.10
Awarded
August 27, 2026
Period of Performance
Aug 27, 2026 – Sep 01, 2026
Identifier
36C24526N0839
NAICS
325412
This award represents a BPA call contract under a blanket purchase agreement with Takeda Pharmaceuticals America, Inc., a global biopharmaceutical company specializing in innovative medicines. The contract procures TAKHZYRO 150 MG, a pharmaceutical product essential for specific therapeutic treatments. This procurement is significant for the agency's healthcare supply chain, ensuring timely access to critical medication. The scope covers the delivery of the specified drug within a short-term timeframe in Brooks, Kentucky. The contract was issued as a call under an existing BPA, allowing for streamlined acquisition without competitive bidding for this specific call. The contract spans a brief performance period designated in late August to early September. This order follows the parent blanket purchase agreement established in March 2026, which permits multiple one-year options, reflecting a strategic approach to pharmaceutical procurement for sustained agency needs.
Description
TAKHZYRO 150 MG